Sociodemographic Disparities in Sodium-Glucose Co-Transporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists Prescription Patterns Among Patients With Poorly Controlled Diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sociodemographic Disparities in Sodium-Glucose Co-Transporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists Prescription Patterns Among Patients With Poorly Controlled Diabetes

Published:2024-03-24 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Antwi-Amoabeng Daniel,Beutler Bryce D,Ghuman Jasmine,Ulanja Mark B,Ghuman Joban,Gullapalli Nageshwara

Publisher

Springer Science and Business Media LLC

Reference30 articles.

1. SGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trials;Inzucchi SE;Diab Vasc Dis Res,2015

2. Oral semaglutide: a review of the first oral glucagon-like peptide 1 receptor agonist;Bucheit JD;Diabetes Technol Ther,2020

3. Sodium-glucose co-transporter-2 inhibitors and all-cause mortality: a meta-analysis of randomized controlled trials;Silverii GA;Diabetes Obes Metab,2021

4. The development of oral semaglutide, an oral GLP-1 analog, for the treatment of type 2 diabetes;Rasmussen MF;Diabetol Int,2020

5. SGLT2 inhibitors: the star in the treatment of type 2 diabetes?;Saisho Y;Diseases,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP